US 12,263,304 B1
Face mask impregnated with medicine
Jon E Hilliard, Gastonia, NC (US)
Filed by Jon E Hilliard, Gastonia, NC (US)
Filed on Sep. 21, 2021, as Appl. No. 17/480,703.
Claims priority of provisional application 63/125,487, filed on Dec. 15, 2020.
Int. Cl. A61M 16/06 (2006.01); A45D 44/00 (2006.01); A61M 35/00 (2006.01); A62B 18/08 (2006.01); A62B 23/02 (2006.01); B01D 39/08 (2006.01)
CPC A61M 16/06 (2013.01) [A45D 44/002 (2013.01); A61M 35/10 (2019.05); A62B 18/084 (2013.01); A62B 23/025 (2013.01); B01D 39/08 (2013.01); B01D 2239/0478 (2013.01); B01D 2239/0654 (2013.01)] 14 Claims
OG exemplary drawing
 
2. A face mask impregnated with medicine comprising
a mask structure, a fastening structure, and a medical coating;
wherein the fastening structure attaches to the mask structure;
wherein the medical coating is applied to the mask structure;
wherein the mask structure comprises an inner layer, a filter layer, and an outer layer;
wherein the filter layer is sandwiched between the inner layer and the outer layer;
wherein the medical coating is configured to be applied to the face of the inner layer that is proximal to the face of the patient;
wherein the medical coating is selected from the group consisting of: a) a pharmacologically active media with a primary chemical structure of (all-trans)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (CAS 302-79-4); and, b) a pharmacologically active media with a primary chemical structure of α-[[(1.1-Dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol (CAS 18559-94-9).